Reversal of endothelin-1 release by stimulation of endothelial α2- adrenoceptor contributes to cerebral vasorelaxation

Hypertension

Volumn 30, Issue 4, 1997, Pages 830-836

  Thorin, Eric ^a,b   Shreeve, S Martin ^a   Thorin Trescases, Nathalie ^a   Bevan, John A ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Artery, cerebral; Endothelin 1; Endothelium; Human; Rabbits; Receptors, adrenergic

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; BRIMONIDINE; CLONIDINE; ENDOTHELIN 1; HISTAMINE; INDOMETACIN; N(G) NITROARGININE; OXYMETAZOLINE; PHENYLEPHRINE; RAUWOLSCINE; SEROTONIN; YOHIMBINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MIDDLE CEREBRAL ARTERY; NONHUMAN; PIA ARTERY; PRIORITY JOURNAL; STROKE; VASCULAR SMOOTH MUSCLE;

EID: 0030876456     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.4.830     Document Type: Article

References (43)

1. Tasaka K, Kitazumi K. The control of endothelin-1 secretion. Gen Pharmacol. 1994;25:1059-1069.
2. Harder DR. Pressure-induced myogenic activation of cat cerebral arteries is dependent on intact endothelium. Circ Res. 1987;60: 102-107.
3. Palmer RMJ, Ferridge AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
4. Moncada S. Prostacyclin/thromboxane-mediated mechanisms in platelet-vascular wall interactions. In: Hayaishi O, Yamamoto S, eds. Advances in Prostaglandin, Thromboxane, and Leukotriene Research. New York, NY: Raven Press; 1985;15:507-512.
5. Garland CJ, Plane F, Kemp BK, Cocks TM. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci. 1995;16:23-30.
6. Yanagizawa M, Kirihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415.
7. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
8. Levin ER. Mechanisms of disease: endothelins. N Engl J Med. 1995;333:356-363.
9. Hirose H, Ide K, Sasaki T, Takahashi R, Kobayashi M, Ikemoto F, Yano M, Nishikibe M. The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Eur J Pharmacol. 1995;277:77-87.
10. Dohi Y, Hahn AWA, Boulanger CM, Bühler FR, Lüscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992;19:131-137.
11. Chen L, McNeill JR, Wilson TW, Gopalakrishnan V. Heterogeneity in vascular smooth muscle responsiveness to angiotensin, II: role of endothelin. Hypertension. 1995;26:83-88.
12. Bockman CS, Jeffries WB, Abel PW. Binding and functional characterization of alpha-2 adrenergic receptor subtypes on pig vascular endothelium. J Pharmacol Exp Ther. 1993;267:1126-1133.
13. Ohgushi M, Yasue H, Kugiyama K, Murohara T, Sakaino N. Contraction and endothelium dependent relaxation via alpha adrenoceptors are variable in various pig arteries. Cardiovasc Res. 1993; 27:779-784.
14. 2,-adrenoceptor-mediated dilations in rat cerebral arteries. Am J Physiol. 1995;269: H1171-H1174.
15. Dunn W, Wellman G, Bevan JA. Enhanced resistance artery sensitivity to agonists under isobaric compared to isometric conditions. Am J Physiol. 1994;266:H147-H155.
16. Thorin E, Shatos MA, Shreeve SM, Walters CL, Bevan JA. Human vascular endothelium heterogeneity: a comparative study of cerebral and peripheral cultured vascular endothelial cells. Stroke 1997;28:375-381.
17. Bevan JA, Duckles SP, Lee TJ-F. Histamine potentiation of nerve-and drug-induced responses of rabbit cerebral artery. Circ Res. 1975;36:647-653.
18. Van Riper D, Bevan JA. Selective variation of agonist and neurally mediated vasoconstriction with rabbit middle cerebral artery branch order. J Pharmacol Exp Ther. 1991;257:879-885.
19. Rees DD, Palmer RMJ, Schultz R, Hodson HF, Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
20. 1-adrenoceptor subtypes: studies using radioligand binding and reverse transcription-polymerase chain reaction analysis. Br J Pharmacol. 1996;118: 1246-1252.
21. Perez DM, Piascik MT, Malik N, Gaivin R, Graham RM. Cloning, expression, and tissue distribution of the rat homolog of the bovine alpha 1C-adrenergic receptor provide evidence for its classification as the alpha 1A subtype. Mol Pharmacol. 1994;46:823-831.
22. Brayden JE. Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation. Am J Physiol. 1990;259: H668-H677.
23. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science. 1992;256: 532-535.
24. Petersson J, Zygmunt PM, Brandt L, Högesstätt ED. Substance P-induced relaxation and hyperpolarization in human cerebral arteries. Br J Pharmacol. 1995;115:889-894.
25. Murphy ME, Brayden JE. Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J Physiol. 1995;486:47-58.
26. 2. Mol Pharmacol. 1994;45:696-702.
27. 2-adrenergic receptors. FASEB J. 1992;6:832-839.
28. iα2. J Biol Chem. 1993;268:19528-19533.
29. Yanagizawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, Nakajima K, Watanabe TX, Sakakibara S, Goto K, Masaki T. Primary structure, synthesis, and biological activity of rat endothelin, and endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A. 1988;85:6964-6967.
30. Oliver FJ, de la Rubia G, Feener EP, Lee ME, Loeken MR, Shiba T, Quertermous T, King GL. Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem. 1991;266: 23251-23256.
31. Boulanger CM, Tanner FC, Béa ML, Hahn AWA, Werner A, Lüscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. Circ Res. 1992;70:1191-1197.
32. Yoshizumi M, Kurihara H, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y. Hemodynamic shear stress stimulates endothelin-1 production by cultured endothelial cells. Biochem Biophys Res Commun. 1989;161:859-864.
33. Henrion D, Laher T. Potentiation of norepinephrine-induced contractions by endothelin-1 in the rabbit aorta. Hypertension. 1993;22: 78-83.
34. Yang Z, Richard V, von Segesser L, Bauer E, Stulz P, Turina M, Lüscher T. Threshold concentrations of endothelin-1 potentiate contractions to norepinephrine and serotonin in human arteries. Circulation. 1990;82:188-195.
35. Gogfraind T. Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol. 1993;110: 1201-1205.
36. Boulanger CM, Lüscher TF. Release of endothelin by porcine aorta: inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990;85:587-590.
37. Ohbayashi A, Hiraga T, Okubo M, Murase T, Matsushita H, Hara M. Characteristics of porcine coronary artery endothelial cells in culture: comparison with aortic endothelium. Biochem Biophys Res Commun. 1994;202:504-511.
38. Harrison VJ, Barnes K, Turner AJ, Wood E, Corder R, Vane JR. Identification of endothelin 1 and big-endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1995;92:6344-6348.
39. Cocks TM, Angus JA. Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature. 1983;305: 627-630.
40. 2-adrenoceptor mediated cerebral vasodilation is altered in hypertension. Arch Mal Coeur Vaiss. 1995;88:23. Abstract.
41. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 1990;325:997-1001.
42. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K. Raised plasma endothelin in aneurysmal subarachnoid haemorrhage. Lancet. 1989;2:1402.
43. Zuccarello M, Soattin GB, Lewis AI, Breu V, Hallak H, Rapoport RM. Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonist. J Neurosurg. 1996;84:503-507.